ObsEva S.A. (SIX: OBSN)

https://www.obseva.com

ObsEva is a biopharmaceutical company developing novel therapies to improve women’s reproductive health and pregnancy. ObsEva has established a development program focused on improving in vitro fertilization success rates. ObsEva is listed on the Nasdaq Capital Market and is traded under the ticker symbol “OBSV” and on the SIX Swiss Exchange where it is traded under the ticker symbol “OBSN”. *

	Start	2012-01-01 established
	Group	ObsEva (Group)
	Industry	nolasiban (OBE001)
	Industry 2	reproductive health
	Person	Loumaye, Ernest (ObsEva 201211– CEO + Co-founder before PregLem SA CEO + founder + Ipsen + Serono)
	Person 2	Adams, Timothy M. (Tim) (ObsEva 201701– CFO located in US before Demandware + athenahealth + Cytyc)

	Region	Plan-les-Ouates GE
	Country	Switzerland
	Street	12 Chemin des Aulx
	City	1228 Plan-les-Ouates GE
	Tel	+41-22-552-3840
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: ObsEva S.A.. (2/24/23). "Press Release: ObsEva Announces Strategic Reorganization to Consolidate Operations in Switzerland". Geneva.

		Record changed: 2025-03-16